PDA

View Full Version : Basic Patent Law


  1. Basic Patent Law Section of the EQE Forum
  2. Provisional schedule for new topics on Basic Patent Law for discussion
  3. Novelty - selection and overlapping ranges
  4. Novelty - the two-list principle
  5. Novelty - medical uses
  6. Inventive step - Problem/Solution - Closest prior art
  7. Inventive step - Problem/Solution - Objective technical problem
  8. Inventive step - Problem/Solution - Assessment of inventive step
  9. Priority - Basics
  10. Languages - Translations after grant
  11. Clarity
  12. Sufficiency
  13. Unity of Invention
  14. Further processing
  15. Re-establishment
  16. Euro-PCT claiming WTO priority?
  17. product-by-process: novelty
  18. Ten-days rule
  19. Guidelines and Case Law?
  20. Partial problems assessment of inventive step
  21. Added subject matter
  22. Re-establishment of rights as remedy for failure to pay claims fee?
  23. Rule 40 (3): Certified copies automatically taken into the file by the EPO
  24. Priority: "leaving no rights outstanding" [A87(4)]
  25. Re-establishment
  26. Correction of errors
  27. Patentable inventions
  28. Non-prejudicial disclosures
  29. priority claim
  30. Renewal fees - 3-month prepayment period?
  31. Articles on Basic Patent Law - why that ?
  32. Articles on Basic Patent Law - why that ?
  33. R. 57(g) and invite under R. 58?
  34. Fee increases - can old fee really be paid within six months?
  35. Language reduction for Euro-PCT
  36. Further processing + refund vs. 112(2) decision
  37. R 45(3) EPC vs A113(2) EPC
  38. Priority: First Application non-PC/ WTO State
  39. Appeal against the grant of own patent
  40. The new G decisions...
  41. Third party observations
  42. Withdrawn Priority application
  43. Conversion due to European prior rights
  44. Stay of opposition proceedings
  45. Common representatice - PCT and withdrawel
  46. Date of filing and time until publication of a Divisional
  47. Filing by reference - Wiki page
  48. Zusatzgebühr? R.38 <-> R.17 & R.36
  49. Filing fee reduction for divisional?
  50. Claim amendments
  51. Supreme Court rules that business methods may be patentable
  52. Who can apply?
  53. Countries for which the EPO may act as IPEA
  54. Date of filing not changing - R. 40(3), R. 55, Guidelines...
  55. Publication and divisional application?
  56. priority right lost in Opposiiont Proceedings?
  57. European Attorney representing a US client for Chapter II?
  58. Inventor Names, priority vs application
  59. Rule 62a and Rule 63
  60. Opposition and Limitation
  61. Difference applicant and proprietor
  62. Divisional application
  63. Prior art and breach of confidentiality
  64. Clarification of example in GLE regarding novelty
  65. Infringement-Equivalent Question
  66. Availability of a product as prior art
  67. Request for conservation of evidence
  68. Art. 115 Rule 114 (2)
  69. R. 62a: does it applies also AFTER the search report?
  70. Declaration of priority R. 52(2) and (3)
  71. novelty based on commercial name
  72. Pending limitation proceedings
  73. Signature of Representative "on behalf"
  74. invention of selection
  75. R 162 - Period of grace of Euro-PCT
  76. directorate of Principal Directorate Tools
  77. Priority, missing date or country
  78. Priority WTO
  79. Opposition and representation
  80. "served as a basis for claiming a right of priority"?
  81. Enlarged Board of Appeal Decisions G2/07 and G1/08
  82. R134(1) (Extension of periods)
  83. Novelty issue?
  84. Observations by third parties - nature and publication
  85. Internal vs. External Priority
  86. Unity of invention / Multiple independent claims
  87. International exhibition
  88. One independent claim per category (R. 43(2) vs 44(1))
  89. New ranges to claims with regard to A. 123(2)
  90. Ranges and subranges
  91. priority document not sent to the EPO
  92. Insufficient payment and further processing
  93. Extension under R132(2) for invitation under R59
  94. Use of "wherein" in claims
  95. Refusal, appeal and renewal fee
  96. concurrent Revocation and Opposition
  97. G4/95 submissions in oral proceedings
  98. EPO is RO and national security - conversion
  99. Rule 121(4) objection to an expert
  100. Priority and selection ranges
  101. Interruption of proceedings
  102. lack of unity
  103. Correction under r139 epc
  104. Revocation proceedings & non-entitled applicant
  105. Aggregate time periods
  106. PCT entering regional phase and filing fee
  107. claiming priority from ABANDONED application
  108. R14 resumption
  109. Question: "in or for the same state" A.87(4)
  110. Representation
  111. Skilled person - suff. disclosure
  112. urgent Help EPC Rule 142 and dissolved company
  113. question regarding Professional representative and insolvency
  114. Languages for divisional
  115. Rule 52(4) vs Rule 139
  116. 2011 Rule 70 and Rule 70a
  117. Rule 18(2)
  118. Rule 70a
  119. Referencing Supplement to OJ 1/2011
  120. OJ 2011 & the filing of sequence listings
  121. R163(1)
  122. R50(3) 2nd sentence and R132(2)
  123. Rule 69
  124. Filing an application in an authorized non-official language
  125. SESR on PCT entering regional phase before EPO
  126. Priority - "First application"
  127. Filing by reference R40(2) and R40(3) - Declaration of complete translation R53(3)
  128. Novelty - Introduction
  129. Novelty - Selection and overlapping ranges - 2011
  130. Gl c v 3.4
  131. Novelty - the two-lists principle
  132. Rule 133 and OJ EPO 2007, SE 3, I.1.
  133. Rules 37(2) and 39(2) EPC and GL A-XI 10.2.6 (French version)
  134. New Fees
  135. Rule 62a and Guidelines C-VI,5.6
  136. Pending application - R. 36(1) and A. 121/122.
  137. Divisional Applicaion / Rule 36(1) b) EPC
  138. Filing of a EP application: the stress starts to kick in
  139. Extent of opposition, G9/91 and A105
  140. National fee according to A22(1) and A25(2)a PCT for EPO
  141. A128 and A54(3)
  142. Correcting declaration of priority, application of R52(3)
  143. priority A87 and transfer of rights